Definitive Healthcare Corp. (NASDAQ:DH) Stock Rated "Reduce" by Wall Street Analysts

Key Points

• Analysts have a consensus “Reduce” rating on Definitive Healthcare, with three sell ratings, six holds and one strong-buy rating. The average 12-month price target is $1.47, though recent targets range from $0.70 to $1.50.
• DH opened at $0.98 and has traded between $0.61 and $3.15 over the past year. The company’s latest quarterly EPS of $0.05 exceeded expectations, but revenue of $55.2 million fell slightly short and net margin remained deeply negative at 72.28%.
• Institutional investors own 98.67% of the stock, with several funds recently increasing their positions or initiating new stakes.

Shares of Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) have earned an average rating of "Reduce" from the ten research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $1.47.

Several research firms have commented on DH. Morgan Stanley dropped their price objective on shares of Definitive Healthcare from $2.50 to $1.50 and set an "equal weight" rating for the company in a report on Tuesday, August 11th. Bank of America reaffirmed an "underperform" rating and issued a $0.70 target price on shares of Definitive Healthcare in a report on Monday, June 29th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Definitive Healthcare in a research report on Monday, August 31st. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Sunday, September 13th. Finally, BTIG Research restated a "neutral" rating on shares of Definitive Healthcare in a report on Friday, September 4th.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $0.98 on Friday. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.81. Definitive Healthcare has a twelve month low of $0.61 and a twelve month high of $3.15. The business has a 50-day moving average price of $0.87 and a 200-day moving average price of $0.88. The firm has a market cap of $104.61 million, a price-to-earnings ratio of -0.61, a price-to-earnings-growth ratio of 11.92 and a beta of 1.40.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. The firm had revenue of $55.20 million for the quarter, compared to analysts' expectations of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, equities research analysts predict that Definitive Healthcare will post 0.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Definitive Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Williams & Novak Wealth Management LLC lifted its stake in shares of Definitive Healthcare by 15.3% in the 3rd quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company's stock valued at $82,000 after purchasing an additional 12,000 shares during the last quarter. Squarepoint Ops LLC increased its position in shares of Definitive Healthcare by 46.5% during the 2nd quarter. Squarepoint Ops LLC now owns 351,575 shares of the company's stock valued at $292,000 after purchasing an additional 111,634 shares during the last quarter. Corient Private Wealth LP purchased a new stake in Definitive Healthcare during the 2nd quarter valued at $378,000. Williams & Novak LLC raised its holdings in Definitive Healthcare by 155.8% during the 2nd quarter. Williams & Novak LLC now owns 78,610 shares of the company's stock valued at $65,000 after buying an additional 47,880 shares during the period. Finally, Irenic Capital Management LP bought a new stake in Definitive Healthcare in the first quarter worth $71,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp. is a healthcare commercial intelligence company that provides data, analytics and software to help organizations understand the healthcare market. Its platform is designed to support decision-making across areas such as sales and marketing, market access, provider network strategy, competitive intelligence and healthcare operations.

The company's products combine information on healthcare providers, hospitals, health systems, medical groups, payers, procedures and related market activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.